BPC-157 is not a steroid. It is a peptide, a short chain of 15 amino acids with a molecular weight of about 1,420 daltons. Steroids and peptides are fundamentally different classes of molecules, built from different raw materials, structured differently, and acting on the body through entirely separate mechanisms. The confusion likely comes from the fact that BPC-157 appears on banned substance lists in sports and is marketed for recovery and healing, areas where anabolic steroids also show up.
What BPC-157 Actually Is
BPC stands for “Body Protection Compound.” The peptide is a synthetic fragment derived from a larger protein naturally found in human gastric juice, first isolated by researchers in the early 1990s. Its amino acid sequence (glycine-glutamic acid-proline-proline-proline-glycine-lysine-proline-alanine-aspartic acid-aspartic acid-alanine-glycine-leucine-valine) is manufactured in a lab through solid-phase peptide synthesis. The FDA’s Global Substance Registration System classifies it as a protein.
Unlike a hormone your body produces in large quantities to regulate broad systems, BPC-157 appears to work by influencing local repair processes. In animal studies, it promotes the growth of new blood vessels by increasing the activity of a receptor called VEGFR2 and by stimulating nitric oxide production through an enzyme in blood vessel walls. Nitric oxide relaxes blood vessels and supports tissue repair, which helps explain why the peptide has shown healing effects across so many different tissue types in preclinical research.
How Peptides Differ From Steroids
The distinction between peptides and steroids starts at the molecular level. Steroids are built from cholesterol, a fat-based molecule with a rigid four-ring structure. That greasy, fat-soluble backbone lets steroids slip directly through cell membranes and bind to receptors inside the cell nucleus, where they switch genes on or off. Testosterone, estrogen, and cortisol all work this way.
Peptides like BPC-157 are chains of amino acids, the same building blocks that make up every protein in your body. They dissolve in water and cannot pass through cell membranes on their own. Instead, they dock onto receptors on the outside surface of cells and trigger signaling cascades inside, like pressing a doorbell rather than walking through the wall. This is a completely different mechanism from how steroids operate, and it means BPC-157 does not have the hormonal effects associated with anabolic steroids, such as suppressing your body’s natural testosterone production, altering sex characteristics, or causing liver toxicity.
Why It Gets Confused With Steroids
BPC-157 occupies a similar cultural space to performance-enhancing drugs. It is marketed heavily in fitness and bodybuilding communities for injury recovery, and it is banned in competitive sports. The World Anti-Doping Agency prohibits it under category S0 (Unapproved Substances), not under the anabolic steroid category. That distinction matters: it is banned because it has no approved medical use and could provide a competitive advantage, not because it is chemically related to steroids.
The U.S. Anti-Doping Agency explicitly describes BPC-157 as an “experimental peptide.” If you are a competitive athlete subject to drug testing, it will result in a violation. But the violation would be for using an unapproved substance, not for steroid use.
What Animal Research Shows
Most of what we know about BPC-157 comes from rat studies, which have been extensive. In preclinical models, the peptide consistently accelerates healing of tendons, ligaments, and muscles. Rats with severed Achilles tendons showed improved function, greater biomechanical strength, better collagen organization, and faster blood vessel formation at the injury site. Similar results appeared in studies of quadriceps muscle transection, crush injuries, and even muscle wasting caused by tumors.
The peptide has also been studied in eye injuries (corneal ulcer healing), nerve damage, spinal cord compression, and various gastrointestinal conditions. In a small human study, 11 of 12 patients reported significant improvement in knee pain after a single injection, with benefits lasting more than a year. A phase II trial in ulcerative colitis reported no adverse effects. But the overall body of human evidence remains thin.
Current Regulatory Status
BPC-157 is not approved by the FDA for any medical use. It previously appeared on the FDA’s list of bulk drug substances that compounding pharmacies could potentially use, but the nominations were withdrawn. The FDA has announced it plans to consult its Pharmacy Compounding Advisory Committee in July 2026 about whether BPC-157 acetate and BPC-157 free base should be added to the approved compounding list.
A Phase 1 safety trial (NCT02637284) tested oral tablets containing 1 mg of BPC-157 in healthy volunteers, but the study’s status is listed as unknown and no results have been posted. This means we still lack the kind of rigorous human safety data that would normally support a drug approval. The products currently sold online as BPC-157 are unregulated, and their purity, dosing accuracy, and sterility are not guaranteed by any oversight body.
The Bottom Line on Classification
BPC-157 is a 15-amino-acid peptide derived from a protein in stomach juice. It is not a steroid, not built from cholesterol, and does not interact with steroid hormone receptors. It works on the surface of cells rather than inside the nucleus, primarily through pathways involved in blood vessel growth and nitric oxide signaling. While it shares shelf space with steroids in the supplement and performance-enhancement world, the two substances have almost nothing in common biologically.